Unknown

Dataset Information

0

Synthesis and evaluation of indenoisoquinoline topoisomerase I inhibitors substituted with nitrogen heterocycles.


ABSTRACT: In connection with an ongoing investigation of indenoisoquinoline topoisomerase I (Top1) inhibitors as potential therapeutic agents, the pharmacophore possessing di(methoxy) and methylenedioxy substituents was held constant, and new derivatives were synthesized with nitrogen heterocycles appended to the lactam side chain. Compounds were evaluated for Top1 inhibition and for cytotoxicity in the National Cancer Institute's human cancer cell screen. Some of the more potent derivatives were also screened for in vivo activity in a hollow fiber assay. The results of these studies indicate that lactam substituents possessing nitrogen heterocycles can provide highly cytotoxic compounds with potent Top1 inhibition. Molecular modeling of these compounds in complex with DNA and Top1 suggests that some of the lactam substituents are capable of interacting with the DNA base pairs above and below the site of intercalation and/or with Top1 amino acid residues, resulting in increased biological activity.

SUBMITTER: Nagarajan M 

PROVIDER: S-EPMC2526314 | biostudies-literature | 2006 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Synthesis and evaluation of indenoisoquinoline topoisomerase I inhibitors substituted with nitrogen heterocycles.

Nagarajan Muthukaman M   Morrell Andrew A   Ioanoviciu Alexandra A   Antony Smitha S   Kohlhagen Glenda G   Agama Keli K   Hollingshead Melinda M   Pommier Yves Y   Cushman Mark M  

Journal of medicinal chemistry 20061001 21


In connection with an ongoing investigation of indenoisoquinoline topoisomerase I (Top1) inhibitors as potential therapeutic agents, the pharmacophore possessing di(methoxy) and methylenedioxy substituents was held constant, and new derivatives were synthesized with nitrogen heterocycles appended to the lactam side chain. Compounds were evaluated for Top1 inhibition and for cytotoxicity in the National Cancer Institute's human cancer cell screen. Some of the more potent derivatives were also scr  ...[more]

Similar Datasets

| S-EPMC3983348 | biostudies-literature
| S-EPMC2538619 | biostudies-literature
| S-EPMC4789169 | biostudies-literature
| S-EPMC4991562 | biostudies-literature
| S-EPMC4558194 | biostudies-literature
| S-EPMC8725971 | biostudies-literature
| S-EPMC6128714 | biostudies-literature
| S-EPMC10572568 | biostudies-literature
| S-EPMC3043142 | biostudies-literature
| S-EPMC6312717 | biostudies-literature